ALTIMMUNE, INC. Common Stock, Value, Issued
ALTIMMUNE, INC. (ALT) had Common Stock, Value, Issued of $19.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-12
- 2026-06-30: Common Stock, Value, Issued $19.00K.
- 2026-03-31: Common Stock, Value, Issued $13.00K.
- 2025-12-31: Common Stock, Value, Issued $11.00K.
- 2025-09-30: Common Stock, Value, Issued $10.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $19.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $13.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $11.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $10.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $9.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $8.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $7.00K 10-K · filed 2026-03-06 | |
| 2024-09-30 | $7.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $7.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $7.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $7.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $5.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $5.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $5.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $5.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $5.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.00K 10-K · filed 2023-02-28 | $4.09K 10-K · filed 2022-03-15 |
| 2021-09-30 | $3.96K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $3.96K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $3.81K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $3.70K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $3.29K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $2.63K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $1.51K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.51K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.50K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.31K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.31K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $876.00 10-K · filed 2020-03-27 | |
| 2018-09-30 | $173.00 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $3.74K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.23K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $61.00 10-K · filed 2019-04-01 | $1.81K 10-K · filed 2018-04-02 |
| 2017-09-30 | $1.56K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.54K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $6.88K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $692.00 10-K · filed 2018-04-02 | $6.77K 10-K · filed 2017-03-14 |
| 2016-09-30 | $6.64K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $6.48K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $6.44K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $6.44K 10-K · filed 2017-03-14 | |
| 2015-09-30 | $6.44K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $6.39K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $6.37K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $6.36K 10-K · filed 2016-03-11 | |
| 2014-09-30 | $6.22K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $5.55K 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $5.38K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $5.23K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $5.23K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $5.12K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $4.84K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $4.83K 10-K · filed 2014-03-11 | |
| 2012-09-30 | $4.83K 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $4.83K 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $4.83K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $4.82K 10-K · filed 2013-03-14 | |
| 2011-09-30 | $4.82K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $4.82K 10-Q · filed 2011-08-11 | |
| 2010-12-31 | $4.62K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |